SCHEMBL7141955

SCHEMBL7141955

CC(C)(C)OC(=O)Nc1cc(N2CCOC2=O)c(-c2ccc(F)cc2)cc1NC(=O)CC(=O)c1cccc(-n2ccnc2)c1

nearest known ligand 0.37

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
KDM4D Q6B0I6 1/20 0.36
ABL1 P00519 2/20 0.35
L3MBTL1 Q9Y468 1/20 0.33
PDE4A P27815 1/20 0.32
PDE4B Q07343 1/20 0.32
PDE4C Q08493 1/20 0.32
PDE4D Q08499 1/20 0.32
CCKBR P32239 1/20 0.32
ROCK2 O75116 1/20 0.32
KDM1A O60341 2/20 0.31
MAOA P21397 2/20 0.31
MAOB P27338 2/20 0.31
KDM1B Q8NB78 2/20 0.31
RCOR1 Q9UKL0 2/20 0.31
CCR3 P51677 1/20 0.31
BACE1 P56817 1/20 0.31
TTK P33981 1/20 0.31
CSF1R P07333 1/20 0.31
CYP17A1 P05093 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7138021 0.86 KDM4D (0.35) KDM4DABL1L3MBTL1ROCK2CCR3
SCHEMBL7146597 0.85 ADH5 (0.41) KDM4DABL1L3MBTL1PDE4APDE4B
SCHEMBL7143394 0.84 ADH5 (0.40) KDM4DABL1L3MBTL1PDE4APDE4B
SCHEMBL7703166 0.84 VCP (0.34) ABL1CCR3BACE1
SCHEMBL7147242 0.83 ABL1 (0.41) KDM4DABL1L3MBTL1PDE4APDE4B
SCHEMBL7139934 0.83 ABL1 (0.41) KDM4DABL1L3MBTL1PDE4APDE4B
SCHEMBL7144093 0.83 KDM4D (0.36) KDM4DABL1L3MBTL1CCKBRCCR3
SCHEMBL7141841 0.83 KDM4D (0.35) KDM4DABL1L3MBTL1CCKBRCCR3
SCHEMBL5868843 0.82 CYP17A1 (0.42) KDM4DABL1L3MBTL1PDE4APDE4B
SCHEMBL7139808 0.82 ABL1 (0.39) KDM4DABL1L3MBTL1PDE4APDE4B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1224174-B1 BENZODIAZEPINE DERIVATIVES AS METABOTROPIC GLUTAMATE RECEPTOR ANTAGONISTS HOFFMANN LA ROCHE (CH) 2003-09-17 EP disclosed
US-6407094-B1 4-5-DIDEHYDRO-1,5-BENZODIAZEPIN-2-ONE DERIVATIVES; PSYCHOLOGICAL, NERVOUS SYSTEM, AND BRAIN DISORDERS; COGNITION ACTIVATORS; ALZHEIMER*S DISEASE, SCHIZOPHRENIA HOFFMANN-LA ROCHE INC. 2002-06-18 US disclosed